Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis

Liver Transplantation

Volumn 17, Issue 7, 2011, Pages 814-823

  Borg, Brian B ^a   Seetharam, Anil ^a   Subramanian, Vijay ^a   Basha, Haseeb Ilias ^a   Lisker Melman, Mauricio ^a   Korenblat, Kevin ^a   Anderson, Christopher D ^a   Shenoy, Surendra ^a   Chapman, William C ^a   Crippin, Jeffrey S ^a   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIGEN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 4; COLLAGEN TYPE 5; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VIMENTIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; TH1 CELL; TH17 CELL; TH2 CELL;

ADULT; AGED; CHRONIC DISEASE; COHORT STUDIES; COLLAGEN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS C; HUMANS; IMMUNE SYSTEM; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 79959828566     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22303     Document Type: Article

References (46)

1. Wong JB, McQuillan GM, McHutchison JG, Poynard T,. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562-1569.
2. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317-322.
3. Seeff LB,. Natural history of chronic hepatitis C. Hepatology 2002; 36 (5 suppl 1): S35-S46. (Pubitemid 35253462)
4. Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, et al. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol 2009; 24: 581-587.
5. Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM,. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection. J Viral Hepat 2009; 16: 492-499.
6. Gane EJ,. The natural history of recurrent hepatitis C and what influences this. Liver Transpl 2008; 14 (suppl 2): S36-S44.
7. Rodriguez-Luna H, Vargas HE,. Natural history of hepatitis C and outcomes following liver transplantation. Minerva Gastroenterol Dietol 2004; 50: 51-59. (Pubitemid 38649526)
8. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167-177. (Pubitemid 26021616)
9. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21: 30-34.
10. Charlton M, Wiesner R,. Natural history and management of hepatitis C infection after liver transplantation. Semin Liver Dis 2004; 24 (suppl 2): 79-88. (Pubitemid 39180710)
11. Rauterberg J, Voss B, Pott G, Gerlach U,. Connective tissue components of the normal and fibrotic liver. I. Structure, local distribution and metabolism of connective tissue components in the normal liver and changes in chronic liver diseases. Klin Wochenschr 1981; 59: 767-779. (Pubitemid 11071727)
12. Seyer JM, Hutcheson ET, Kang AH,. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 1977; 59: 241-248. (Pubitemid 8055682)
13. Giannelli G, Antonaci S,. Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection. Histol Histopathol 2005; 20: 939-944. (Pubitemid 40932611)
14. Iwata T, Philipovskiy A, Fisher AJ, Presson RG Jr, Chiyo M, Lee J, et al. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 2008; 181: 5738-5747.
15. Mahesh B, Leong HS, McCormack A, Sarathchandra P, Holder A, Rose ML,. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol 2007; 170: 1415-1427. (Pubitemid 47339348)
16. Dragun D, Muller DN, Brasen JH, Fritsche L, Nieminen-Kelha M, Dechend R, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558-569. (Pubitemid 40204669)
17. Zauli D, Cassani F, Bianchi FB,. Auto-antibodies in hepatitis C. Biomed Pharmacother 1999; 53: 234-241.
18. Luo JC, Hwang SJ, Li CP, Lu RH, Chan CY, Wu JC, et al. Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype. J Gastroenterol Hepatol 1998; 13: 475-479.
19. Suou T, Hirayama C,. Antibodies to denatured bovine collagens in sera of patients with liver disease. Clin Exp Immunol 1980; 39: 119-124. (Pubitemid 10173657)
20. Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T,. Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol 2003; 64: 224-230. (Pubitemid 36197350)
21. Bharat A, Barros F, Narayanan K, Borg B, Lisker-Melman M, Shenoy S, et al. Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis. Am J Transplant 2008; 8: 1214-1220. (Pubitemid 351763698)
22. Batts KP, Ludwig J,. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417.
23. Bharat A, Saini D, Steward N, Hachem R, Trulock EP, Patterson GA, et al. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg 2010; 90: 1094-1101.
24. Nath DS, Ilias Basha H, Tiriveedhi V, Alur C, Phelan D, Ewald GA, et al. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy. J Heart Lung Transplant 2010; 29: 1277-1285.
25. Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P,. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev 2008; 8: 18-23.
26. Buskila D,. Hepatitis C-associated rheumatic disorders. Rheum Dis Clin North Am 2009; 35: 111-123.
27. Zachou K, Liaskos C, Christodoulou DK, Kardasi M, Papadamou G, Gatselis N, et al. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest 2003; 33: 161-168. (Pubitemid 36250086)
28. Bai L, Feng ZR, Lu HY, Li WG, Yu M, Xu XY,. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China. Chin Med J (Engl) 2009; 122: 5-9.
29. Williams MJ, Lawson A, Neal KR, Ryder SD, Irving WL,. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat 2009; 16: 325-331.
30. Chretien P, Chousterman M, Abd Alsamad I, Ozenne V, Rosa I, Barrault C, et al. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. J Autoimmun 2009; 32: 201-205.
31. Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ, et al. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C. J Clin Pathol 2008; 61: 333-337.
32. Fukami N, Ramachandran S, Saini D, Walter M, Chapman W, Patterson GA, Mohanakumar T,. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 2009; 182: 309-318.
33. Goers TA, Ramachandran S, Aloush A, Trulock E, Patterson GA, Mohanakumar T,. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008; 180: 4487-4494.
34. Fedoseyeva EV, Zhang F, Orr PL, Levin D, Buncke HJ, Benichou G,. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999; 162: 6836-6842. (Pubitemid 29309412)
35. Caldas C, Luna E, Spadafora-Ferreira M, Porto G, Iwai LK, Oshiro SE, et al. Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses. Clin Exp Immunol 2006; 146: 66-75. (Pubitemid 44393840)
36. Takai KK, Hattori S, Irie S,. Type V collagen distribution in liver is reconstructed in coculture system of hepatocytes and stellate cells; the possible functions of type V collagen in liver under normal and pathological conditions. Cell Struct Funct 2001; 26: 289-302. (Pubitemid 34110815)
37. Yamamoto M, Sumiyoshi H, Nakagami K, Tahara E,. Distribution of collagen types I, III, and V in fibrotic and neoplastic human liver. Acta Pathol Jpn 1984; 34: 77-86. (Pubitemid 14164211)
38. Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, Anderson CD, et al. Characterization of HCV Specific CD4+Th17 Immunity in Recurrent Hepatitis C Induced Liver Allograft Fibrosis. Am J Transplant. 2011; 11: 775-785.
39. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9: 166-175.
40. Bhogal RK, Bona CA,. B cells: no longer bystanders in liver fibrosis. J Clin Invest 2005; 115: 2962-2965. (Pubitemid 41567558)
41. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU, Kim HY,. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther 2004; 6: R120-R128.
42. Bortolami M, Kotsafti A, Cardin R, Farinati F,. Fas/FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease. J Viral Hepat 2008; 15: 515-522. (Pubitemid 351798989)
43. Oyanagi Y, Takahashi T, Matsui S, Takahashi S, Boku S, Takahashi K, et al. Enhanced expression of interleukin-6 in chronic hepatitis C. Liver 1999; 19: 464-472. (Pubitemid 30019059)
44. Reiser M, Marousis CG, Nelson DR, Lauer G, Gonzalez-Peralta RP, Davis GL, Lau JY,. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 1997; 26: 471-478. (Pubitemid 27112709)
45. Wan L, Kung YJ, Lin YJ, Liao CC, Sheu JJ, Tsai Y, et al. Th1 and Th2 cytokines are elevated in HCV-infected SVR(-) patients treated with interferon-alpha. Biochem Biophys Res Commun 2009; 379: 855-860.
46. Gangadharan B, Antrobus R, Dwek RA, Zitzmann N,. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem 2007; 53: 1792-1799. (Pubitemid 47509672)